Guilford Expects Medicare Payment Boost For Gliadel Starting Oct. 1
Executive Summary
A new Medicare hospital payment category covering Guilford's Gliadel Wafer is expected to raise the reimbursement rate for the chemotherapy implant effective Oct. 1
You may also be interested in...
Activase May Be Reclassified With Separate DRG Under Medicare Part A
The Centers for Medicare & Medicaid Services is considering the creation of a separate diagnosis-related group for the use of drugs like Genentech's Activase to treat ischemic strokes under Medicare Part A
Activase May Be Reclassified With Separate DRG Under Medicare Part A
The Centers for Medicare & Medicaid Services is considering the creation of a separate diagnosis-related group for the use of drugs like Genentech's Activase to treat ischemic strokes under Medicare Part A
Xigris Medicare Reimbursement: CMS Resisting New Severe Sepsis Code
The Centers for Medicare & Medicaid Services plans to reimburse Lilly's sepsis agent Xigris using existing reimbursement codes